Investigating the particle engineering of colistin for pulmonary delivery

David Morton, Teresa Jong, Jian Li, John Hale, Roger Nation, Ian Larson

Research output: Chapter in Book/Report/Conference proceedingConference PaperResearchpeer-review

Abstract

Lung infections represent a significant cause of mortaility to specific patient groups, notably custic fibrosis patients. While antibiotics have been effective against infection - causing pathogenuic bacteria such as Pseudomonas aeruginosa, the onset of antibiotic resistance has been a major concern and meant that alternative antibiotics and/or delivery mechanisms are required to achieve effective treatment.
Original languageEnglish
Title of host publicationRespiratory Drug Delivery Europe 2011
EditorsRichard N Dalby, Peter R Byron, Joanne Peart, Julie D Suman, Paul M Young
Place of PublicationUSA
PublisherVCU Respiratory Drug Delivery
Pages367 - 371
Number of pages5
ISBN (Print)1933722517
Publication statusPublished - 2011
EventRespiratory Drug Delivery 2011 - Intercontinental Hotel, Berlin, Germany
Duration: 3 May 20116 May 2011

Conference

ConferenceRespiratory Drug Delivery 2011
CountryGermany
CityBerlin
Period3/05/116/05/11

Cite this

Morton, D., Jong, T., Li, J., Hale, J., Nation, R., & Larson, I. (2011). Investigating the particle engineering of colistin for pulmonary delivery. In R. N. Dalby, P. R. Byron, J. Peart, J. D. Suman, & P. M. Young (Eds.), Respiratory Drug Delivery Europe 2011 (pp. 367 - 371). USA: VCU Respiratory Drug Delivery.
Morton, David ; Jong, Teresa ; Li, Jian ; Hale, John ; Nation, Roger ; Larson, Ian. / Investigating the particle engineering of colistin for pulmonary delivery. Respiratory Drug Delivery Europe 2011. editor / Richard N Dalby ; Peter R Byron ; Joanne Peart ; Julie D Suman ; Paul M Young. USA : VCU Respiratory Drug Delivery, 2011. pp. 367 - 371
@inproceedings{4e5d1ff1c03a46389b8faf3e730d10cb,
title = "Investigating the particle engineering of colistin for pulmonary delivery",
abstract = "Lung infections represent a significant cause of mortaility to specific patient groups, notably custic fibrosis patients. While antibiotics have been effective against infection - causing pathogenuic bacteria such as Pseudomonas aeruginosa, the onset of antibiotic resistance has been a major concern and meant that alternative antibiotics and/or delivery mechanisms are required to achieve effective treatment.",
author = "David Morton and Teresa Jong and Jian Li and John Hale and Roger Nation and Ian Larson",
year = "2011",
language = "English",
isbn = "1933722517",
pages = "367 -- 371",
editor = "Dalby, {Richard N} and Byron, {Peter R} and Joanne Peart and Suman, {Julie D} and Young, {Paul M}",
booktitle = "Respiratory Drug Delivery Europe 2011",
publisher = "VCU Respiratory Drug Delivery",

}

Morton, D, Jong, T, Li, J, Hale, J, Nation, R & Larson, I 2011, Investigating the particle engineering of colistin for pulmonary delivery. in RN Dalby, PR Byron, J Peart, JD Suman & PM Young (eds), Respiratory Drug Delivery Europe 2011. VCU Respiratory Drug Delivery, USA, pp. 367 - 371, Respiratory Drug Delivery 2011, Berlin, Germany, 3/05/11.

Investigating the particle engineering of colistin for pulmonary delivery. / Morton, David; Jong, Teresa; Li, Jian; Hale, John; Nation, Roger; Larson, Ian.

Respiratory Drug Delivery Europe 2011. ed. / Richard N Dalby; Peter R Byron; Joanne Peart; Julie D Suman; Paul M Young. USA : VCU Respiratory Drug Delivery, 2011. p. 367 - 371.

Research output: Chapter in Book/Report/Conference proceedingConference PaperResearchpeer-review

TY - GEN

T1 - Investigating the particle engineering of colistin for pulmonary delivery

AU - Morton, David

AU - Jong, Teresa

AU - Li, Jian

AU - Hale, John

AU - Nation, Roger

AU - Larson, Ian

PY - 2011

Y1 - 2011

N2 - Lung infections represent a significant cause of mortaility to specific patient groups, notably custic fibrosis patients. While antibiotics have been effective against infection - causing pathogenuic bacteria such as Pseudomonas aeruginosa, the onset of antibiotic resistance has been a major concern and meant that alternative antibiotics and/or delivery mechanisms are required to achieve effective treatment.

AB - Lung infections represent a significant cause of mortaility to specific patient groups, notably custic fibrosis patients. While antibiotics have been effective against infection - causing pathogenuic bacteria such as Pseudomonas aeruginosa, the onset of antibiotic resistance has been a major concern and meant that alternative antibiotics and/or delivery mechanisms are required to achieve effective treatment.

M3 - Conference Paper

SN - 1933722517

SP - 367

EP - 371

BT - Respiratory Drug Delivery Europe 2011

A2 - Dalby, Richard N

A2 - Byron, Peter R

A2 - Peart, Joanne

A2 - Suman, Julie D

A2 - Young, Paul M

PB - VCU Respiratory Drug Delivery

CY - USA

ER -

Morton D, Jong T, Li J, Hale J, Nation R, Larson I. Investigating the particle engineering of colistin for pulmonary delivery. In Dalby RN, Byron PR, Peart J, Suman JD, Young PM, editors, Respiratory Drug Delivery Europe 2011. USA: VCU Respiratory Drug Delivery. 2011. p. 367 - 371